185 related articles for article (PubMed ID: 32996067)
1. Systematic Literature Review of Economic Evaluations, Costs/Resource Use, and Quality of Life in Patients with Mantle Cell Lymphoma.
Monga N; Garside J; Davids MS; Tam C; Ward K; Fotheringham I; O'Donovan P; Parisi L; Tapprich C
Pharmacoecon Open; 2021 Jun; 5(2):175-186. PubMed ID: 32996067
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews.
Monga N; Garside J; Gurung B; Quigley J; O'Donovan P; Tapprich C; Nastoupil L; Thieblemont C; Loefgren C
Pharmacoecon Open; 2020 Dec; 4(4):575-591. PubMed ID: 32200522
[TBL] [Abstract][Full Text] [Related]
3. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis.
Cichewicz A; Tencer T; Gupte-Singh K; Egodage S; Burnett H; Kumar J
Adv Ther; 2023 May; 40(5):2116-2146. PubMed ID: 37000363
[TBL] [Abstract][Full Text] [Related]
5. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
[TBL] [Abstract][Full Text] [Related]
6. Systematic literature review of the global burden of illness of mantle cell lymphoma.
Monga N; Garside J; Quigley J; Hudson M; O'Donovan P; O'Rourke J; Tapprich C; Parisi L; Davids MS; Tam C
Curr Med Res Opin; 2020 May; 36(5):843-852. PubMed ID: 32162977
[No Abstract] [Full Text] [Related]
7. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review of Time and Resource Use Costs of Subcutaneous Versus Intravenous Administration of Oncology Biologics in a Hospital Setting.
McCloskey C; Ortega MT; Nair S; Garcia MJ; Manevy F
Pharmacoecon Open; 2023 Jan; 7(1):3-36. PubMed ID: 35996066
[TBL] [Abstract][Full Text] [Related]
9. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
10. The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation.
Frampton G; Harris P; Cooper K; Lotery A; Shepherd J
Health Technol Assess; 2014 Nov; 18(68):1-205, v-vi. PubMed ID: 25405576
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of economic evaluations in second and later lines of therapy for the treatment of non-small cell lung cancer.
Jäkel A; Plested M; Dharamshi K; Modha R; Bridge S; Johns A
Appl Health Econ Health Policy; 2013 Feb; 11(1):27-43. PubMed ID: 23329379
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of the quality and scope of economic evaluations in child oral health research.
Rogers HJ; Rodd HD; Vermaire JH; Stevens K; Knapp R; El Yousfi S; Marshman Z
BMC Oral Health; 2019 Jul; 19(1):132. PubMed ID: 31262293
[TBL] [Abstract][Full Text] [Related]
13. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
[TBL] [Abstract][Full Text] [Related]
14. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.
Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N
Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420
[TBL] [Abstract][Full Text] [Related]
15. Virtual chromoendoscopy for the real-time assessment of colorectal polyps in vivo: a systematic review and economic evaluation.
Picot J; Rose M; Cooper K; Pickett K; Lord J; Harris P; Whyte S; Böhning D; Shepherd J
Health Technol Assess; 2017 Dec; 21(79):1-308. PubMed ID: 29271339
[TBL] [Abstract][Full Text] [Related]
16. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
[TBL] [Abstract][Full Text] [Related]
17. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
18. Housing improvements for health and associated socio-economic outcomes.
Thomson H; Thomas S; Sellstrom E; Petticrew M
Cochrane Database Syst Rev; 2013 Feb; (2):CD008657. PubMed ID: 23450585
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
